遺伝子ノックアウト細胞株 検証済
リコンビナント
RabMAb

Anti-Integrin alpha 2 抗体 [EPR17338] - C-terminal (ab181548)

ab181548 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab181548 は 7 報の論文で使用されています。

  • Li G  et al. Functional characterization of a potent anti-tumor polysaccharide in a mouse model of gastric cancer. Life Sci 219:11-19 (2019). PubMed: 30611785
  • Wei Q  et al. Low-concentration HCP1 inhibits apoptosis in vascular endothelial cells. Biochem Biophys Res Commun 511:92-98 (2019). PubMed: 30770100
  • Zhao G  et al. Cullin5 deficiency promotes small-cell lung cancer metastasis by stabilizing integrin ß1. J Clin Invest 129:972-987 (2019). PubMed: 30688657
  • Sikorski K  et al. A high-throughput pipeline for validation of antibodies. Nat Methods 15:909-912 (2018). PubMed: 30377371
  • Mishra SJ  et al. Transformation of the Non-Selective Aminocyclohexanol-Based Hsp90 Inhibitor into a Grp94-Seletive Scaffold. ACS Chem Biol 12:244-253 (2017). PubMed: 27959508
  • van de Weijer ML  et al. Multiple E2 ubiquitin-conjugating enzymes regulate human cytomegalovirus US2-mediated immunoreceptor downregulation. J Cell Sci 130:2883-2892 (2017). PubMed: 28743740
  • Ghosh S  et al. Endoplasmic Reticulum Resident Heat Shock Protein 90 (Hsp90) Isoform Glucose-Regulated Protein 94 (Grp94) Regulates Cell Polarity and Cancer Cell Migration by Affecting Intracellular Transport. J Biol Chem N/A:N/A (2016). WB ; Human . PubMed: 26872972

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

登録